Tony Zibo Zhuang

6PUBLICATIONS
46CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 29, 2025
A Phase I Trial of Evorpacept, Lenalidomide, and Rituximab for Patients with B-Cell Non-Hodgkin Lymphoma.

Paolo Strati, Lei Feng, Andrey Tyshevich

|Jan 15, 2025
Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution Experience.

Tony Z Zhuang, Subir Goyal, Katherine B Case

|May 13, 2024
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas.

Rahul S Bhansali, Fredrik Ellin, Thomas Relander

|Oct 25, 2023
Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature.

Joshua D Preston, Caroline S Jansen, Siddhartha Kosaraju

|Nov 25, 2022
Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.

Tony Z Zhuang, Deepak Ravindranathan, Yuan Liu

|Jun 24, 2022
Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials.

Tony Zibo Zhuang, Katherine Case, Timothy Anders Olsen

Pageof 1

Frequent Collaborators

2 joint publications

Pamela B Allen

1 joint publications

Bassel Nazha

1 joint publications

Joshua D Preston

1 joint publications

Caroline S Jansen